79 related articles for article (PubMed ID: 7525036)
21. Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402.
Kudo A; Shinoda M; Ariizumi S; Kumamoto T; Katayama M; Otsubo T; Endo I; Kitagawa Y; Tanabe M; Yamamoto M;
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2949-2956. PubMed ID: 32462296
[TBL] [Abstract][Full Text] [Related]
22. Chinese expert consensus statement on the clinical application of AFP/AFP-L3%/DCP using GALAD and GALAD-like algorithm in HCC.
Huang C; Xiao X; Zhou L; Chen F; Wang J; Hu X; Gao C;
J Clin Lab Anal; 2023 Dec; 37(23-24):e24990. PubMed ID: 38063322
[TBL] [Abstract][Full Text] [Related]
23. Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma.
Mohyeldeen M; Ibrahim S; Shaker O; Helmy H
Clin Biochem; 2020 Oct; 84():38-44. PubMed ID: 32526227
[TBL] [Abstract][Full Text] [Related]
24. DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study.
Kotwani P; Chan W; Yao F; Mehta N
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):701-703.e2. PubMed ID: 33524592
[TBL] [Abstract][Full Text] [Related]
25. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma.
Chalasani NP; Porter K; Bhattacharya A; Book AJ; Neis BM; Xiong KM; Ramasubramanian TS; Edwards DK; Chen I; Johnson S; Roberts LR; Kisiel JB; Reddy KR; Singal AG; Olson MC; Bruinsma JJ
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):173-182.e7. PubMed ID: 34391922
[TBL] [Abstract][Full Text] [Related]
26. Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Manuc D; Preda CM; Sandra I; Baicus C; Cerban R; Constantinescu I; Olteanu AO; Ciora CA; Manuc T; Chiriac DE; Chifulescu AE; Diculescu M; Tieranu C; Negreanu L; Oprea-Calin G; Manuc M
J Med Life; 2020; 13(1):68-74. PubMed ID: 32341704
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis.
Chen J; Wu G; Li Y
Dis Markers; 2018; 2018():8906023. PubMed ID: 30402170
[TBL] [Abstract][Full Text] [Related]
28. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.
Mehta N; Kotwani P; Norman J; Shui A; Li PJ; Saxena V; Chan W; Yao FY
Liver Transpl; 2023 Oct; 29(10):1041-1049. PubMed ID: 37159217
[TBL] [Abstract][Full Text] [Related]
29. Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
Shimagaki T; Yoshio S; Kawai H; Sakamoto Y; Doi H; Matsuda M; Mori T; Osawa Y; Fukai M; Yoshida T; Ma Y; Akita T; Tanaka J; Taketomi A; Hanayama R; Yoshizumi T; Mori M; Kanto T
Sci Rep; 2019 Oct; 9(1):15788. PubMed ID: 31673081
[TBL] [Abstract][Full Text] [Related]
30. Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control Study.
Hu B; Wei LU; Liang H; Su M; Wang R; Su T; Li Q; Yin Q; Feng Y; Jiang J
Anticancer Res; 2023 Sep; 43(9):3997-4005. PubMed ID: 37648308
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related.
Nguyen HB; Le XT; Nguyen HH; Vo TT; Le MK; Nguyen NT; Do-Nguyen TM; Truong-Nguyen CM; Nguyen BT
Cancer Inform; 2022; 21():11769351221100730. PubMed ID: 35614962
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.
Pan YX; Sun XQ; Hu ZL; Xie W; Nie KX; Fang AP; Zhang YY; Fu YZ; Chen JB; Wang JC; Wang X; Zhang YJ; Hu DD; Chen MS
J Hepatocell Carcinoma; 2021; 8():657-670. PubMed ID: 34235104
[TBL] [Abstract][Full Text] [Related]
33. A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma.
Zenlander R; Fredolini C; Schwenk JM; Rydén I; Påhlsson P; Löwbeer C; Eggertsen G; Stål P
Scand J Gastroenterol; 2023; 58(9):998-1008. PubMed ID: 37017178
[TBL] [Abstract][Full Text] [Related]
34. Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.
Jin YJ; Aycheh HM; Han S; Chamberlin J; Shin J; Byun S; Lee Y
BMC Med Genomics; 2020 Dec; 13(Suppl 11):194. PubMed ID: 33371894
[TBL] [Abstract][Full Text] [Related]
35. Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy.
Qu C; Wang Y; Wang P; Chen K; Wang M; Zeng H; Lu J; Song Q; Diplas BH; Tan D; Fan C; Guo Q; Zhu Z; Yin H; Jiang L; Chen X; Zhao H; He H; Wang Y; Li G; Bi X; Zhao X; Chen T; Tang H; Lv C; Wang D; Chen W; Zhou J; Zhao H; Cai J; Wang X; Wang S; Yan H; Zeng YX; Cavenee WK; Jiao Y
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6308-6312. PubMed ID: 30858324
[TBL] [Abstract][Full Text] [Related]
36. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosis.
Aboelfotoh AO; Foda EM; Elghandour AM; Teama NM; Abouzein RA; Mohamed GA
Arab J Gastroenterol; 2020 Jun; 21(2):80-84. PubMed ID: 32439236
[TBL] [Abstract][Full Text] [Related]
37. BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort study.
Wongjarupong N; Negron-Ocasio GM; Mara KC; Prasai K; Abdallah MA; Ahn KS; Yang JD; Addissie BD; Giama NH; Harmsen WS; Therneau TM; Roberts LR
HPB (Oxford); 2021 May; 23(5):762-769. PubMed ID: 33023823
[TBL] [Abstract][Full Text] [Related]
38. The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages.
Nagahara T; Sugihara T; Kihara T; Ikeda S; Hoshino Y; Matsuki Y; Sakaguchi T; Kurumi H; Onoyama T; Takata T; Matono T; Yamaguchi N; Isomoto H
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672339
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of des-γ-carboxyprothrombin in patients with AFP-negative HCC treated with TACE.
Sun H; Yang W; Zhou W; Zhou C; Liu S; Shi H; Tian W
Oncol Lett; 2023 Feb; 25(2):69. PubMed ID: 36644150
[TBL] [Abstract][Full Text] [Related]
40. HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma.
Bai Y; Xu J; Li D; Zhang X; Chen D; Xie F; Huang L; Yu X; Zhao H; Zhang Y
Clin Epigenetics; 2023 Jun; 15(1):99. PubMed ID: 37308980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
